65 results on '"Uraoka, N"'
Search Results
2. Correction: Signal peptidase complex 18, encoded by SEC11A, contributes to progression via TGF-α secretion in gastric cancer
- Author
-
Oue, N, Naito, Y, Hayashi, T, Takigahira, M, Kawano-Nagatsuma, A, Sentani, K, Sakamoto, N, Oo, H Z, Uraoka, N, Yanagihara, K, Ochiai, A, Sasaki, H, and Yasui, W
- Published
- 2019
- Full Text
- View/download PDF
3. Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer
- Author
-
Federico, L., primary, McGrail, D.J., additional, Bentebibel, S.-E., additional, Haymaker, C., additional, Ravelli, A., additional, Forget, M.-A., additional, Karpinets, T., additional, Jiang, P., additional, Reuben, A., additional, Negrao, M.V., additional, Li, J., additional, Khairullah, R., additional, Zhang, J., additional, Weissferdt, A., additional, Vaporciyan, A.A., additional, Antonoff, M.B., additional, Walsh, G., additional, Lin, S.-Y., additional, Futreal, A., additional, Wistuba, I., additional, Roth, J., additional, Byers, L.A., additional, Gaudreau, P.-O., additional, Uraoka, N., additional, Cruz, A.F., additional, Dejima, H., additional, Lazcano, R.N., additional, Solis, L.M., additional, Parra, E.R., additional, Lee, J.J., additional, Swisher, S., additional, Cascone, T., additional, Heymach, J.V., additional, Sepesi, B., additional, Gibbons, D.L., additional, and Bernatchez, C., additional
- Published
- 2022
- Full Text
- View/download PDF
4. Signal peptidase complex 18, encoded by SEC11A, contributes to progression via TGF-α secretion in gastric cancer
- Author
-
Oue, N, Naito, Y, Hayashi, T, Takigahira, M, Kawano-Nagatsuma, A, Sentani, K, Sakamoto, N, Zarni Oo, H, Uraoka, N, Yanagihara, K, Ochiai, A, Sasaki, H, and Yasui, W
- Published
- 2014
- Full Text
- View/download PDF
5. ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis
- Author
-
Peng, D H, primary, Ungewiss, C, additional, Tong, P, additional, Byers, L A, additional, Wang, J, additional, Canales, J R, additional, Villalobos, P A, additional, Uraoka, N, additional, Mino, B, additional, Behrens, C, additional, Wistuba, I I, additional, Han, R I, additional, Wanna, C A, additional, Fahrenholtz, M, additional, Grande-Allen, K J, additional, Creighton, C J, additional, and Gibbons, D L, additional
- Published
- 2016
- Full Text
- View/download PDF
6. Signal peptidase complex 18, encoded by SEC11A, contributes to progression via TGF-α secretion in gastric cancer
- Author
-
Oue, N, primary, Naito, Y, additional, Hayashi, T, additional, Takigahira, M, additional, Kawano-Nagatsuma, A, additional, Sentani, K, additional, Sakamoto, N, additional, Zarni Oo, H, additional, Uraoka, N, additional, Yanagihara, K, additional, Ochiai, A, additional, Sasaki, H, additional, and Yasui, W, additional
- Published
- 2013
- Full Text
- View/download PDF
7. Upregulation of HOXA10 in gastric cancer with the intestinal mucin phenotype: reduction during tumor progression and favorable prognosis
- Author
-
Sentani, K., primary, Oue, N., additional, Naito, Y., additional, Sakamoto, N., additional, Anami, K., additional, Oo, H. Z., additional, Uraoka, N., additional, Aoyagi, K., additional, Sasaki, H., additional, and Yasui, W., additional
- Published
- 2012
- Full Text
- View/download PDF
8. ChemInform Abstract: Synthesis of Disulfides by the Oxidative Coupling of Thiols with Calcium Hypochlorite and Silica Gel in Hexane.
- Author
-
HIRANO, M., primary, YAKABE, S., additional, URAOKA, N., additional, and MORIMOTO, T., additional
- Published
- 2010
- Full Text
- View/download PDF
9. Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small cell lung cancer
- Author
-
Federico, L, primary, McGrail, DJ, additional, Bentebibel, SE, additional, Haymaker, C, additional, Ravelli, A, additional, Forget, MA, additional, Karpinets, T, additional, Jiang, P, additional, Reuben, A, additional, Negrao, MV, additional, Li, J, additional, Khairullah, R, additional, Zhang, J, additional, Weissferdt, A, additional, Vaporciyan, AA, additional, Antonoff, MB, additional, Walsh, G, additional, Lin, SY, additional, Futreal, A, additional, Wistuba, I, additional, Roth, J, additional, Byers, LA, additional, Gaudreau, PO, additional, Uraoka, N, additional, Francisco-Cruz, A, additional, Dejima, H, additional, Lazcano, RN, additional, Solis, LM, additional, Parra, ER, additional, Lee, JJ, additional, Swisher, S, additional, Cascone, T, additional, Heymach, JV, additional, Sepesi, B, additional, Gibbons, DL, additional, and Bernatchez, C, additional
- Full Text
- View/download PDF
10. ChemInform Abstract: Synthesis of Disulfides by the Oxidative Coupling of Thiols with Calcium Hypochlorite and Silica Gel in Hexane.
- Author
-
HIRANO, M., YAKABE, S., URAOKA, N., and MORIMOTO, T.
- Published
- 1998
- Full Text
- View/download PDF
11. Discovering cancer stem-like molecule, nuclear factor I X, using spatial transcriptome in gastric cancer.
- Author
-
Ishikawa A, Fukui T, Kido A, Katsuya N, Kuraoka K, Uraoka N, Suzuki T, Oka S, Kotachi T, Ashktorab H, Smoot D, and Yasui W
- Abstract
Gastric cancer (GC) is characterized by significant intratumoral heterogeneity, and stem cells are promising therapeutic targets. Despite advancements in spatial transcriptome analyses, unexplored targets for addressing cancer stemness remain unknown. This study aimed to identify Nuclear Factor IX (NFIX) as a critical regulator of cancer stemness in GC and evaluate its clinicopathological significance and function. Spatial transcriptome analysis of GC was conducted. The correlation between NFIX expression, clinicopathological factors, and prognosis was assessed using immunostaining in 127 GC cases. Functional analyses of cancer cell lines validated these findings. Spatial transcriptome analysis stratified GC tissues based on genetic profiles, identified CSC-like cells, and further refined the classification to identify and highlight the significance of NFIX, as validated by Monocle 3 and CytoTRACE analyses. Knockdown experiments in cancer cell lines have demonstrated the involvement of NFIX in cancer cell proliferation and kinase activity. This study underscores the role of spatial transcriptome analysis in refining GC tissue classification and identifying therapeutic targets, highlighting NFIX as a pivotal factor. NFIX expression is correlated with poor prognosis and drives GC progression, suggesting its potential as a novel therapeutic target for personalized GC therapies., (© 2024 The Author(s). Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.)
- Published
- 2024
- Full Text
- View/download PDF
12. MCM4 expression is associated with high-grade histology, tumor progression and poor prognosis in urothelial carcinoma.
- Author
-
Kobayashi G, Hayashi T, Sentani K, Uraoka N, Fukui T, Kido A, Katsuya N, Ishikawa A, Babasaki T, Sekino Y, Nose H, Arihiro K, Hinata N, and Oue N
- Subjects
- Humans, Progression-Free Survival, Urothelium, Minichromosome Maintenance Complex Component 4, Urinary Bladder Neoplasms diagnosis, Carcinoma, Transitional Cell diagnosis, Stomach Neoplasms
- Abstract
Background: We previously reported Minichromosome maintenance 4 (MCM4) overexpression in gastric cancer. However, the clinicopathological significance of MCM4 in urothelial carcinoma (UC) has not been investigated. To clarify the clinicopathological significance of MCM4 in UC, we investigated MCM4 expression with immunohistochemistry (IHC)., Methods: We analyzed the expression and distribution of MCM4 in 124 upper tract urothelial carcinoma (UTUC) samples by IHC. Additionally, using 108 urine samples, we analyzed MCM4 Immunocytochemistry (ICC) expression in urine cytology., Results: In normal urothelium, MCM4 expression was weak or absent. Meanwhile, the strong nuclear expression of MCM4 was observed in UTUC tissues, and it was detected in 77 (62%) of a total of 124 UTUC cases. MCM4-positive UTUC cases were associated with nodular/flat morphology, high grade, high T stage, and poor prognosis. Moreover, MCM4 expression was significantly higher in the invasive front than in the tumor surface. Similar results were also obtained in TCGA bladder cancer cohort. Additionally, MCM4 expression was associated with high expression of Ki-67, HER2, EGFR, and p53 in UTUC. Among representative cancer-related molecules, MCM4 had an independent predictive value for progression-free survival and high-grade UC. ICC for MCM4 was also performed on urine cytology slides and showed that the nuclear expression of MCM4 was more frequently found in UC cells than in non-neoplastic cells. The diagnostic accuracy of urine cytology was improved by combining MCM4 immunostaining with cytology., Conclusion: These results suggest that MCM4 might be a useful predictive biomarker for high-grade histology, tumor progression and poor prognosis in UC. Moreover, ICC for MCM4 might be helpful for UC detection as additional markers in the cytomorphology-based diagnosis., (© 2023. BioMed Central Ltd., part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
13. Clinicopathological significance of TUBB3 in upper tract urothelial carcinoma and possible application in urine cytology.
- Author
-
Kobayashi G, Hayashi T, Sentani K, Uraoka N, Fukui T, Kido A, Katsuya N, Ishikawa A, Babasaki T, Sekino Y, Nose H, Hinata N, and Oue N
- Subjects
- Humans, Tubulin, Cytodiagnosis, Carcinoma, Transitional Cell diagnosis, Urinary Bladder Neoplasms diagnosis, Kidney Neoplasms diagnosis
- Abstract
βIII-Tubulin, encoded by the TUBB3 gene, is a microtubule protein. We previously reported that TUBB3 is overexpressed in renal cell carcinoma. We investigated the clinicopathological significance of TUBB3 in upper tract urothelial carcinoma (UTUC) by immunohistochemistry. In normal tissue, TUBB3 expression was weak or absent. In contrast, TUBB3 overexpression was observed in urothelial carcinoma (UC) tissues in 51 (49%) of 103 UTUC cases. TUBB3 overexpression was associated with nodular/flat morphology, high-grade disease, high T stage, and a poor prognosis. Similar results were obtained in The Cancer Genome Atlas bladder cancer cohort. TUBB3 expression was also associated with high Ki-67 labeling index, CD44v9, HER2, EGFR, and p53 expression in UTUC. Among representative cancer-related molecules, TUBB3 was an independent predictor of progression-free survival and high-grade UC. Finally, using urine cytology samples, we analyzed TUBB3 expression by immunocytochemistry. TUBB3 expression was more frequently found in UC cells than in nonneoplastic cells. The diagnostic accuracy of urine cytology was improved when combined with TUBB3 immunostaining. The findings suggest the importance of TUBB3 in tumor progression and its potential application as a biomarker for high-grade disease and the prognosis of UC. Moreover, combination with TUBB3 immunostaining might improve the diagnostic accuracy of urine cytology., (© 2023 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
14. Dual immunocytochemical staining of annexin A10 and p53 in low-grade and papillary urothelial carcinoma contributes to improvement of diagnostic accuracy in urine cytology.
- Author
-
Kobayashi G, Hayashi T, Sentani K, Uraoka N, Shibata J, Nobuhiro R, Saito Y, Ishida K, Kaneko Y, Ikeda K, Hanamoto M, Nose H, Arihiro K, Hinata N, and Oue N
- Subjects
- Humans, Tumor Suppressor Protein p53, Annexins, Urine, Carcinoma, Transitional Cell diagnosis, Carcinoma, Transitional Cell pathology, Urinary Bladder Neoplasms pathology
- Abstract
Background: Urothelial carcinoma (UC) is a common type of human cancer and, although urine cytology is a useful method for identifying high-grade UC (HGUC), its ability to diagnose low-grade UC (LGUC) is limited. The authors previously reported that annexin A10 (ANXA10) expression was strongly linked to both papillary and early stage LGUC and was inversely correlated with p53 expression in upper tract UC (UTUC) and bladder UC. However, it remains largely unknown whether ANXA10 is useful as a diagnostic marker for urine cytology., Methods: In this study, the authors used 104 biopsy and 314 urine cytology samples to investigate the efficacy of ANXA10 and p53 expression by immunohistochemistry and immunocytochemistry., Results: In immunohistochemistry analysis, expression levels of ANXA10 and p53 were either weak or absent in noncancerous tissues, whereas ANXA10 overexpression was observed patients with LGUC, and strong expression of p53 was identified in patients with HGUC. In immunocytochemistry analysis, sensitivity was not good for the detection of UC, especially UTUC, by cytology alone, but it was improved by combining cytology with ANXA10 and p53 to detect both bladder UC and UTUC. Receiver operating characteristic curve analysis also confirmed the diagnostic superiority of cytology combining ANXA10 and p53 for the detection of all UCs, including both HGUC and LGUC (area under the curve, 0.84)., Conclusions: To the authors' knowledge, this is the first report that the combination of ANXA10 and p53 has potential application as a diagnostic immunomarker for improving the diagnostic accuracy of urine cytology., (© 2023 American Cancer Society.)
- Published
- 2023
- Full Text
- View/download PDF
15. Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohort.
- Author
-
William WN Jr, Zhang J, Zhao X, Parra ER, Uraoka N, Lin HY, Peng SA, El-Naggar AK, Rodriguez-Canales J, Song J, Gillenwater AM, Wistuba II, Myers JN, Gold KA, Ferrarotto R, Hwu P, Davoli T, Lee JJ, Heymach JV, Papadimitrakopoulou VA, and Lippman SM
- Subjects
- Humans, B7-H1 Antigen, Biomarkers, Tumor genetics, Biomarkers, Tumor metabolism, Genomics, Lymphocytes, Tumor-Infiltrating, Neoplasm Recurrence, Local metabolism, Prospective Studies, Squamous Cell Carcinoma of Head and Neck metabolism, Tumor Microenvironment genetics, Head and Neck Neoplasms metabolism, Mouth Neoplasms genetics, Mouth Neoplasms metabolism
- Abstract
Background: Studies of the immune landscape led to breakthrough trials of programmed death-1 (PD-1) inhibitors for recurrent/metastatic head and neck squamous cell carcinoma therapy. This study investigated the timing, influence of somatic copy-number alterations (SCNAs), and clinical implications of PD-L1 and immune-cell patterns in oral precancer (OPC)., Methods: The authors evaluated spatial CD3, CD3/8, and CD68 density (cells/mm
2 ) and PD-L1 (membranous expression in cytokeratin-positive intraepithelial neoplastic cells and CD68) patterns by multiplex immunofluorescence in a 188-patient prospective OPC cohort, characterized by clinical, histologic, and SCNA risk factors and protocol-specified primary end point of invasive cancer. The authors used Wilcoxon rank-sum and Fisher exact tests, linear mixed effect models, mediation, and Cox regression and recursive-partitioning analyses., Results: Epithelial, but not CD68 immune-cell, PD-L1 expression was detected in 28% of OPCs, correlated with immune-cell infiltration, 9p21.3 loss of heterozygosity (LOH), and inferior oral cancer-free survival (OCFS), notably in OPCs with low CD3/8 cell density, dysplasia, and/or 9p21.3 LOH. High CD3/8 cell density in dysplastic lesions predicted better OCFS and eliminated the excess risk associated with prior oral cancer and dysplasia. PD-L1 and CD3/8 patterns revealed inferior OCFS in PD-L1 high intrinsic induction and dysplastic immune-cold subgroups., Conclusion: This report provides spatial insight into the immune landscape and drivers of OPCs, and a publicly available immunogenomic data set for future precancer interrogation. The data suggest that 9p21.3 LOH triggers an immune-hot inflammatory phenotype; whereas increased 9p deletion size encompassing CD274 at 9p24.1 may contribute to CD3/8 and PD-L1 depletion during invasive transition. The inferior OCFS in PD-L1-high, immune-cold OPCs support the development of T-cell recruitment strategies., (© 2023 American Cancer Society.)- Published
- 2023
- Full Text
- View/download PDF
16. A Case of Bilateral Synchronous Paratesticular Leiomyoma.
- Author
-
Ishikawa A, Uraoka N, Shibata J, Nobuhiro R, Kobayashi G, Saito Y, Nose H, and Oue N
- Abstract
Bilateral synchronous paratesticular leiomyoma (BSPL) is a rare tumor that originates from smooth muscle cells in the paratesticular region. Four BSPL cases have been reported sporadically, starting with the 1991 report by Aus and Boiesen. Herein, we report the case of a 60-year-old male with a bilateral scrotal mass with a maximum size of 7.5 cm. Histological examination revealed oval to spindle-shaped tumor cells with a fascicular growth pattern. Immunohistochemically, the tumor cells were positive for α-smooth muscle actin. The pathological diagnosis was a leiomyoma. Based on the simultaneous bilateral nature of the disease, BSPL was diagnosed. In conclusion, we encountered a rare case of BSPL, and our report may contribute to the understanding of this disease., Competing Interests: The authors have no conflicts of interest to declare., (© 2023 The Author(s). Published by S. Karger AG, Basel.)
- Published
- 2023
- Full Text
- View/download PDF
17. Minichromosome Maintenance 4 Is Associated with Cancer Stemness and Poor Survival of Patients with Gastric Cancer.
- Author
-
Katsuya N, Ishikawa A, Kido A, Fukui T, Kobayashi G, Sekino Y, Uraoka N, Babasaki T, Yasui W, Sentani K, and Oue N
- Subjects
- Humans, Cell Differentiation, Cell Line, Tumor, Cell Proliferation, ErbB Receptors, Neoplastic Stem Cells, DNA Helicases metabolism, Stomach Neoplasms genetics, Stomach Neoplasms pathology
- Abstract
Introduction: Gastric cancer (GC) is a leading cause of cancer-related death worldwide. This study focused on minichromosome maintenance 4 (MCM4), a DNA helicase component that functions in DNA replication. Using spheroid colony formation, having a colony rich in cancer stem cells, this study aimed to investigate the clinicopathological importance of MCM4., Methods: We examined MCM4 expression using quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and immunohistochemistry (IHC) analysis in 10 and 113 GC cases, respectively. MCM4 function in GC was also investigated by RNA interference in GC cell lines., Results: In qRT-PCR and IHC analysis, high MCM4 expression was found in 60% and 83% of GC cases, respectively. MCM4-positive GC cases were significantly associated with higher T grade and tumor stage. Additionally, high MCM4 expression was significantly associated with poor prognosis and was an independent prognostic factor in multivariate analysis. MCM4 was significantly coexpressed with CD133, matrix metalloproteinase 7 (MMP7), epidermal growth factor (EGFR), and mesenchymal-epithelial transition factor (cMET). In GC cell lines, MCM4 knockdown affected cell growth and protein kinase B (Akt), extracellular signal-regulated kinase (ERK), and EGFR pathways., Conclusion: These results indicate that MCM4 expression could be a key regulator in GC progression and is pivotal in treating GC., (© 2022 S. Karger AG, Basel.)
- Published
- 2023
- Full Text
- View/download PDF
18. ANXA10 Expression Is Inversely Associated with Tumor Stage, Grade, and TP53 Expression in Upper and Lower Urothelial Carcinoma.
- Author
-
Kobayashi G, Hayashi T, Sentani K, Ikeda K, Babasaki T, Shigematsu Y, Sekino Y, Uraoka N, Teishima J, Matsubara A, Hinata N, and Oue N
- Subjects
- Humans, Urothelium metabolism, Urothelium pathology, Tumor Suppressor Protein p53 genetics, Tumor Suppressor Protein p53 metabolism, Annexins genetics, Annexins metabolism, Urinary Bladder Neoplasms genetics, Carcinoma, Transitional Cell genetics, Carcinoma, Transitional Cell pathology, Kidney Neoplasms genetics, Ureteral Neoplasms genetics, Ureteral Neoplasms metabolism, Ureteral Neoplasms pathology
- Abstract
Introduction: Urothelial carcinoma (UC) is a common type of malignant disease, but little is known about the diagnostic and prognostic markers of upper urinary tract urothelial cancer (UTUC) because of its rarity. To clarify the significance of ANXA10 in UTUC, we studied ANXA10 expression with immunohistochemistry (IHC)., Methods: The expression of ANXA10 was analyzed in the upper and lower urinary tract of UC by IHC in combination with The Cancer Genome Atlas (TCGA) data analysis. The association between ANXA10 expression and representative cancer-related molecules was also evaluated., Results: ANXA10 expression was weak in normal upper tract urothelium but was positive in 39/117 (33%) UTUCs. ANXA10 was more frequently positive in tumors with pure UC (36%, p < 0.05), papillary morphology (50%, p < 0.01), low grade (G1/2: 57%, p < 0.01), and pTa/is/1 stage (55%, p < 0.01) than in those with histological variants (0%), nodular morphology (9%), G3 (16%), and pT2/3/4 (13%), respectively. ANXA10-positive patients showed better cancer-specific survival and progression-free survival than ANXA10-negative patients (p < 0.05). IHC showed that ANXA10 positivity was detected more in cases with the low expression of TP53 (p < 0.01) and Ki-67 labeling index <20% (p < 0.01). In TCGA dataset of muscle-invasive bladder cancer, higher ANXA10 expression correlated with papillary morphology, lower grade/stage, luminal papillary subtype, wild-type TP53, and FGFR3 gene mutation., Conclusion: We revealed that ANXA10 expression was increased during carcinogenesis and was observed more frequently in papillary UC of lower grade and stage. However, its expression decreased as cancer progressed. Therefore, the ANXA10 expression in UTUC might be clinically useful for decision-making., (© 2022 S. Karger AG, Basel.)
- Published
- 2023
- Full Text
- View/download PDF
19. Clinicopathological significance of the overexpression of MUC1 in upper tract urothelial carcinoma and possible application as a diagnostic marker.
- Author
-
Kobayashi G, Hayashi T, Sentani K, Takemoto K, Sekino Y, Uraoka N, Hanamoto M, Nose H, Teishima J, Arihiro K, Hinata N, and Oue N
- Subjects
- Humans, Mucin-1, Retrospective Studies, Urothelium pathology, Prognosis, Carcinoma, Transitional Cell pathology, Urinary Bladder Neoplasms pathology, Urologic Neoplasms diagnosis, Urologic Neoplasms metabolism, Urologic Neoplasms pathology
- Abstract
Mucin 1 (MUC1) overexpression has been reported in many malignancies and is associated with a poor prognosis. However, the clinicopathological significance of MUC1 in upper tract urothelial carcinoma (UTUC) has not been investigated. We analyzed the expression and distribution of MUC1 in UTUC by immunohistochemistry. In normal urothelium, MUC1 expression was observed on the surface of umbrella cells. Meanwhile, the strong expression of MUC1 was observed in cell membranes and cytoplasm in UTUC tissues, and it was detected in 64 (58%) of a total of 110 UTUC cases. MUC1-positive UTUC cases were associated with nodular/flat morphology, high grade, high T stage, and lymphatic and venous invasion and poor prognosis. Additionally, MUC1 expression was associated with high expression of Ki-67, programmed death-ligand 1 (PD-L1), CD44 variant 9 (CD44v9), human epidermal growth factor receptor 2 (HER2), epidermal growth factor receptor (EGFR), and p53 in UTUC. Furthermore, immunocytochemistry for MUC1 on urine cytology slides demonstrated that the strong staining of MUC1 was more frequently found in tumor cells than in nonneoplastic cells. The diagnostic accuracy of urine cytology was improved by combining MUC1 immunostaining with cytology. These results suggest that MUC1 may be a prognostic biomarker in UTUC, and MUC1 exression has a potential application as a diagnostic immunomarker for urine cytology., (© 2022 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
20. Cytological findings of metastatic poorly differentiated prostate adenocarcinoma to Virchow's node with immunohistochemical positivity for CD10 and negativity for PSA.
- Author
-
Kobayashi G, Sentani K, Uraoka N, Oue N, and Sasaki N
- Subjects
- Humans, Lymphatic Metastasis, Male, Prostate pathology, Prostate-Specific Antigen, Adenocarcinoma diagnosis, Adenocarcinoma pathology, Prostatic Neoplasms diagnosis, Prostatic Neoplasms pathology
- Published
- 2022
- Full Text
- View/download PDF
21. Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer Interception.
- Author
-
Hernandez S, Parra ER, Uraoka N, Tang X, Shen Y, Qiao W, Jiang M, Zhang S, Mino B, Lu W, Pandurengan R, Haymaker C, Affolter K, Scaife CL, Yip-Schneider M, Schmidt CM, Firpo MA, Mulvihill SJ, Koay EJ, Wang H, Wistuba II, Maitra A, Solis LM, and Sen S
- Subjects
- Humans, Tumor Microenvironment, Pancreatic Neoplasms, Adenocarcinoma, Mucinous pathology, Carcinoma, Pancreatic Ductal pathology, Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms pathology
- Abstract
Purpose: Intraductal papillary mucinous neoplasms (IPMN) are bona fide precursors to pancreatic ductal adenocarcinoma (PDAC). While genomic alterations during multistep IPMN progression have been well cataloged, the accompanying changes within the tumor immune microenvironment (TIME) have not been comprehensively studied. Herein, we investigated TIME-related alterations during IPMN progression, using multiplex immunofluorescence (mIF) coupled with high-resolution image analyses., Experimental Design: Two sets of formalin-fixed, paraffin-embedded tissue samples from surgically resected IPMNs were analyzed. The training set of 30 samples consisted of 11 low-grade IPMN (LG-IPMN), 17 high-grade IPMN (HG-IPMN), and 2 IPMN with PDAC, while a validation set of 93 samples comprised of 55 LG-IPMN and 38 HG-IPMN. The training set was analyzed with two panels of immuno-oncology-related biomarkers, while the validation set was analyzed with a subset of markers found significantly altered in the training set., Results: Cell types indicative of enhanced immune surveillance, including cytotoxic and memory T cells, and antigen-experienced T cells and B cells, were all found at higher densities within isolated LG-IPMNs compared with HG-IPMNs. Notably, the TIME of LG-IPMNs that had progressed at the time of surgical resection (progressor LGD) resembled that of the synchronous HG-IPMNs, underscoring that attenuated immune surveillance occurs even in LG-IPMNs destined for progression., Conclusions: Our findings provide a basis for interception of cystic neoplasia to PDAC, through maintenance of sustained immune surveillance using vaccines and other prevention approaches., (©2022 The Authors; Published by the American Association for Cancer Research.)
- Published
- 2022
- Full Text
- View/download PDF
22. Cytological and histological findings of upper tract mucinous urothelial carcinoma with clear cell component: A case report and review of literature.
- Author
-
Kobayashi G, Uraoka N, Sentani K, Shibata J, Nobuhiro R, Saito Y, Taniyama D, Hanamoto M, Nose H, and Oue N
- Subjects
- Aged, 80 and over, Biomarkers, Tumor analysis, Female, Hematuria, Humans, Immunohistochemistry, Nephrectomy, Carcinoma, Transitional Cell pathology, Urinary Bladder Neoplasms pathology
- Abstract
Mucinous urothelial carcinoma (UC) is a rare variant and only 18 cases of mucinous UC have been reported. In this article, we report a case of mucinous UC focusing on both cytological and histological findings. A 92-year-old female was referred to our hospital because of gross hematuria. Clinical computed tomography scan showed 2.2-cm papillary lesion in the lower part of the left ureter. Urine cytology was performed, and cytopathological findings showed that there were a few atypical cells with pale to clear cytoplasm, and a low amount of mucin in the background was identified by periodic acid-schiff (PAS) and alcian blue (AB) staining. Laparoscopic radical nephrectomy of left renal pelvis and ureter was performed. The gross examination revealed that a white-gray, papillary-sessile tumor was found in the lower part of the left ureter. Histologically, conventional high grade UC cells were seen in some areas, and tumor cells in other areas showed abundant clear cytoplasm with extracellular and intracytoplasmic mucin. Immunohistochemical analysis revealed that tumor cells were positive for CK7, CK20, p63, GATA3, MUC1, MUC2, and MUC5AC and negative for MUC6 and CDX2. Histopathological diagnosis was mucinous UC with clear cell component, and the pathological stage was pT1N0M0. The patient has remained well and disease-free for 3 months after the operation. Familiarity and recognizing the characteristic pathological findings of mucinous UC are important because it represents a malignant neoplasm., (© 2021 Wiley Periodicals LLC.)
- Published
- 2022
- Full Text
- View/download PDF
23. Clinicopathological significance of claspin overexpression and its efficacy as a novel biomarker for the diagnosis of urothelial carcinoma.
- Author
-
Kobayashi G, Hayashi T, Sentani K, Babasaki T, Sekino Y, Inoue S, Uraoka N, Hanamoto M, Nose H, Teishima J, Oue N, Matsubara A, Sasaki N, and Yasui W
- Subjects
- Biomarkers analysis, Biomarkers, Tumor analysis, Humans, Urothelium pathology, Carcinoma, Transitional Cell pathology, Kidney Neoplasms pathology, Urinary Bladder Neoplasms pathology
- Abstract
We previously reported that claspin is a key regulator in the progression of gastric cancer and renal cell carcinoma. However, the clinicopathological significance of claspin in urothelial carcinoma (UC) has not been investigated. We analyzed the expression and distribution of claspin in UC cases by immunohistochemistry. In the non-neoplastic urothelium, the expression of claspin was either weak or absent, whereas UC tissues showed nuclear staining. The expression of claspin was detected in 58 (42%) of a total of 138 upper tract UC cases treated by radical nephroureterectomy without neoadjuvant chemotherapy. Claspin-positive UC cases were associated with nodular/flat morphology, variant histology, high tumor grade, high pathological T grade, and lymphatic and venous invasion. The expression of claspin was significantly associated with decreased progression-free survival and cancer-specific survival. In addition, claspin was co-expressed with Ki-67, PD-L1, HER2, EGFR, and p53 in consecutive tumor sections of UC. An immunohistochemical analysis of claspin in biopsy specimens revealed that strong to moderate claspin staining was more frequently observed in carcinoma in situ in comparison to dysplasia or the benign urothelium. Furthermore, immunocytochemistry for claspin on urine cytology slides demonstrated that the proportion of claspin-positive cells was significantly greater in high-grade UC than in benign cases. These results suggest that claspin may be a novel prognostic marker and a possible therapeutic target molecule for UC. Moreover, claspin could be a useful diagnostic biomarker of urothelial neoplasia., (© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
24. Automated 3D scoring of fluorescence in situ hybridization (FISH) using a confocal whole slide imaging scanner.
- Author
-
Frankenstein Z, Uraoka N, Aypar U, Aryeequaye R, Rao M, Hameed M, Zhang Y, and Yagi Y
- Abstract
Fluorescence in situ hybridization (FISH) is a technique to visualize specific DNA/RNA sequences within the cell nuclei and provide the presence, location and structural integrity of genes on chromosomes. A confocal Whole Slide Imaging (WSI) scanner technology has superior depth resolution compared to wide-field fluorescence imaging. Confocal WSI has the ability to perform serial optical sections with specimen imaging, which is critical for 3D tissue reconstruction for volumetric spatial analysis. The standard clinical manual scoring for FISH is labor-intensive, time-consuming and subjective. Application of multi-gene FISH analysis alongside 3D imaging, significantly increase the level of complexity required for an accurate 3D analysis. Therefore, the purpose of this study is to establish automated 3D FISH scoring for z-stack images from confocal WSI scanner. The algorithm and the application we developed, SHIMARIS PAFQ, successfully employs 3D calculations for clear individual cell nuclei segmentation, gene signals detection and distribution of break-apart probes signal patterns, including standard break-apart, and variant patterns due to truncation, and deletion, etc. The analysis was accurate and precise when compared with ground truth clinical manual counting and scoring reported in ten lymphoma and solid tumors cases. The algorithm and the application we developed, SHIMARIS PAFQ, is objective and more efficient than the conventional procedure. It enables the automated counting of more nuclei, precisely detecting additional abnormal signal variations in nuclei patterns and analyzes gigabyte multi-layer stacking imaging data of tissue samples from patients. Currently, we are developing a deep learning algorithm for automated tumor area detection to be integrated with SHIMARIS PAFQ.
- Published
- 2021
- Full Text
- View/download PDF
25. SPC18 Expression Is an Independent Prognostic Indicator of Patients with Esophageal Squamous Cell Carcinoma.
- Author
-
Yamamoto Y, Oue N, Asai R, Katsuya N, Uraoka N, Sakamoto N, Sentani K, Tanabe K, Ohdan H, and Yasui W
- Subjects
- Aged, Cell Line, Tumor, Cell Proliferation, Female, Gene Expression Regulation, Neoplastic, Humans, Immunohistochemistry, Male, Middle Aged, Paraffin Embedding, Prognosis, Retrospective Studies, Signal Transduction, Esophageal Neoplasms diagnosis, Esophageal Neoplasms genetics, Esophageal Squamous Cell Carcinoma diagnosis, Esophageal Squamous Cell Carcinoma genetics, Peptide Hydrolases genetics
- Abstract
Objectives: Esophageal cancer is the sixth most common malignancy worldwide. Signal peptidase complex 18 (SPC18) protein, which is encoded by the SEC11A gene, is one of the subunits of the signal peptidase complex and plays an important role in the secretion of proteins including transforming growth factor α (TGF-α). In this study, we investigated the significance of SPC18 expression in human esophageal squamous cell carcinoma (ESCC)., Methods: SPC18 expression was examined by immunohistochemistry. RNA interference was used to inhibit SPC18 expression in ESCC cell lines. To examine cell viability, we performed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays. The effects of SPC18 inhibition on epidermal growth factor receptor (EGFR) signaling were analyzed by Western blot., Results: In total, 46 (50%) of 92 ESCC cases were positive for SPC18. SPC18 staining was observed more frequently in stage II/III/IV cases than in stage I cases (p = 0.028). We found that SPC18 expression was significantly associated with increased cancer-specific mortality (p = 0.006, log-rank test). SPC18 expression was frequently found in EGFR-positive cases compared with EGFR-negative cases. Cell proliferation and EGFR signaling were inhibited by SPC18 knockdown., Conclusion: Specific inhibitors of SPC18 may be promising anticancer drugs for patients with ESCC., (© 2020 S. Karger AG, Basel.)
- Published
- 2020
- Full Text
- View/download PDF
26. Automatic quantification of HER2 gene amplification in invasive breast cancer from chromogenic in situ hybridization whole slide images.
- Author
-
Hossain MS, Hanna MG, Uraoka N, Nakamura T, Edelweiss M, Brogi E, Hameed MR, Yamaguchi M, Ross DS, and Yagi Y
- Abstract
Human epidermal growth factor receptor 2 (HER2), a transmembrane tyrosine kinase receptor encoded by the ERBB2 gene on chromosome 17q12, is a predictive and prognostic biomarker in invasive breast cancer (BC). Approximately 20% of BC are HER2-positive as a result of ERBB2 gene amplification and overexpression of the HER2 protein. Quantification of HER2 is performed routinely on all invasive BCs, to assist in clinical decision making for prognosis and treatment for HER2 -positive BC patients by manually counting gene signals. We propose an automated system to quantify the HER2 gene status from chromogenic in situ hybridization (CISH) whole slide images (WSI) in invasive BC. The proposed method selects untruncated and nonoverlapped singular nuclei from the cancer regions using color unmixing and machine learning techniques. Then, HER2 and chromosome enumeration probe 17 (CEP17) signals are detected based on the RGB intensity and counted per nucleus. Finally, the HER2 -to-CEP17 signal ratio is calculated to determine the HER2 amplification status following the ASCO/CAP 2018 guidelines. The proposed method reduced the labor and time for the quantification. In the experiment, the correlation coefficient between the proposed automatic CISH quantification method and pathologist manual enumeration was 0.98. The p -values larger than 0.05 from the one-sided paired t -test ensured that the proposed method yields statistically indifferent results to the reference method. The method was established on WSI scanned by two different scanners. Through the experiments, the capability of the proposed system has been demonstrated., (© 2019 Society of Photo-Optical Instrumentation Engineers (SPIE).)
- Published
- 2019
- Full Text
- View/download PDF
27. Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cells.
- Author
-
Oue N, Sentani K, Sakamoto N, Uraoka N, and Yasui W
- Subjects
- Disease Progression, Gene Expression Regulation, Neoplastic, Humans, Phenotype, Prognosis, Stomach Neoplasms classification, Biomarkers, Tumor genetics, Mucins genetics, Neoplastic Stem Cells pathology, Stomach Neoplasms genetics, Stomach Neoplasms pathology
- Abstract
Gastric cancer (GC), one of the most common human cancers, is a heterogeneous disease with different phenotypes, prognoses, and responses to treatment. Understanding the pathogenesis of GC at the molecular level is important for prognosis prediction and determining treatments. Microsatellite instability (MSI), silencing of MLH1, MGMT, and CDKN2A genes by DNA hypermethylation, KRAS mutation, APC mutation, and ERBB2 amplification are frequently found in intestinal type GC. Inactivation of CDH1 and RARB by DNA hypermethylation, and amplification of FGFR and MET, are frequently detected in diffuse type GC. In addition, BST2 and PCDHB9 genes are overexpressed in intestinal type GC. Both genes are associated with GC progression. GC can be divided into gastric/intestinal mucin phenotypes according to mucin expression. MSI, alterations of TP73, CDH1 mutation, and DNA methylation of MLH are detected frequently in the gastric mucin phenotype. TP53 mutation, deletion of APC, and DNA methylation of MGMT are detected frequently in the intestinal mucin phenotype. FKTN is overexpressed in the intestinal mucin phenotype, and IQGAP3 is overexpressed in the gastric mucin phenotype. These genes are involved in GC progression. To characterize cancer stem cells, a useful method is spheroid colony formation. KIFC1 and KIF11 genes show more than twofold higher expression in spheroid-forming cells than that in parental cells. Both KIF genes are overexpressed in GC, and knockdown of these genes inhibits spheroid formation. Alterations of these molecules may be useful to understand gastric carcinogenesis. Specific inhibitors of these molecules may also be promising anticancer drugs.
- Published
- 2019
- Full Text
- View/download PDF
28. Validation of mitotic cell quantification via microscopy and multiple whole-slide scanners.
- Author
-
Tabata K, Uraoka N, Benhamida J, Hanna MG, Sirintrapun SJ, Gallas BD, Gong Q, Aly RG, Emoto K, Matsuda KM, Hameed MR, Klimstra DS, and Yagi Y
- Subjects
- Animals, Dog Diseases drug therapy, Dogs, Image Interpretation, Computer-Assisted, Melanoma diagnosis, Microscopy, Mitosis, Mouth Neoplasms diagnosis, Observer Variation, Pathologists, Reproducibility of Results, Dog Diseases pathology, Melanoma pathology, Mouth Neoplasms pathology
- Abstract
Background: The establishment of whole-slide imaging (WSI) as a medical diagnostic device allows that pathologists may evaluate mitotic activity with this new technology. Furthermore, the image digitalization provides an opportunity to develop algorithms for automatic quantifications, ideally leading to improved reproducibility as compared to the naked eye examination by pathologists. In order to implement them effectively, accuracy of mitotic figure detection using WSI should be investigated. In this study, we aimed to measure pathologist performance in detecting mitotic figures (MFs) using multiple platforms (multiple scanners) and compare the results with those obtained using a brightfield microscope., Methods: Four slides of canine oral melanoma were prepared and digitized using 4 WSI scanners. In these slides, 40 regions of interest (ROIs) were demarcated, and five observers identified the MFs using different viewing modes: microscopy and WSI. We evaluated the inter- and intra-observer agreements between modes with Cohen's Kappa and determined "true" MFs with a consensus panel. We then assessed the accuracy (agreement with truth) using the average of sensitivity and specificity., Results: In the 40 ROIs, 155 candidate MFs were detected by five pathologists; 74 of them were determined to be true MFs. Inter- and intra-observer agreement was mostly "substantial" or greater (Kappa = 0.594-0.939). Accuracy was between 0.632 and 0.843 across all readers and modes. After averaging over readers for each modality, we found that mitosis detection accuracy for 3 of the 4 WSI scanners was significantly less than that of the microscope (p = 0.002, 0.012, and 0.001)., Conclusions: This study is the first to compare WSIs and microscopy in detecting MFs at the level of individual cells. Our results suggest that WSI can be used for mitotic cell detection and offers similar reproducibility to the microscope, with slightly less accuracy.
- Published
- 2019
- Full Text
- View/download PDF
29. SEC11A Expression Is Associated with Basal-Like Bladder Cancer and Predicts Patient Survival.
- Author
-
Shigematsu Y, Oue N, Sekino Y, Sakamoto N, Sentani K, Uraoka N, Hayashi T, Teishima J, Matsubara A, and Yasui W
- Subjects
- Adult, Aged, Cell Line, Tumor, Cell Proliferation, Disease Progression, Female, Gene Expression, Gene Expression Regulation, Neoplastic, Humans, Male, Middle Aged, Neoplasm Invasiveness genetics, Prognosis, Retrospective Studies, Survival Rate, Urinary Bladder Neoplasms physiopathology, Peptide Hydrolases genetics, Urinary Bladder Neoplasms genetics
- Abstract
Objectives: Bladder cancer (BC) is a common malignancy worldwide. Signal peptidase complex 18 (SPC18) protein, which is encoded by the SEC11A gene, is one of the subunits of the signal peptidase complex and induces transforming growth factor-α secretion. In the present study, we analyzed the expression and function of SPC18 protein in human BC., Methods: Expression of SPC18 was analyzed by immunohistochemistry. RNA interference was used to inhibit SEC11A expression in BC cell lines. For constitutive expression of the SEC11A gene, a SEC11A expression vector was transfected into BC cell lines. To examine cell viability, we performed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. Modified Boyden chamber assays were used to examine cell invasiveness., Results: SPC18 was upregulated in 54% of 81 BC cases. SPC18 expression served as an independent prognostic classifier of patients with BC. SPC18-positive BC cases frequently expressed cytokeratin 5/6, a marker of basal-like BC. Cell growth and invasiveness were inhibited by SEC11A knockdown and enhanced by forced expression of SEC11A., Conclusion: These results indicate that SPC18 plays an important role in the progression of BC. Specific inhibitors of SPC18 may be promising anticancer drugs for patients with basal-like BC., (© 2019 S. Karger AG, Basel.)
- Published
- 2019
- Full Text
- View/download PDF
30. A Functional Spatial Analysis Platform for Discovery of Immunological Interactions Predictive of Low-Grade to High-Grade Transition of Pancreatic Intraductal Papillary Mucinous Neoplasms.
- Author
-
Barua S, Solis L, Parra ER, Uraoka N, Jiang M, Wang H, Rodriguez-Canales J, Wistuba I, Maitra A, Sen S, and Rao A
- Abstract
Intraductal papillary mucinous neoplasms (IPMNs), critical precursors of the devastating tumor pancreatic ductal adenocarcinoma (PDAC), are poorly understood in the pancreatic cancer community. Researchers have shown that IPMN patients with high-grade dysplasia have a greater risk of subsequent development of PDAC in the remnant pancreas than do patients with low-grade dysplasia. In this study, we built a computational prediction model that encapsulates the spatial cellular interactions in IPMNs that play key roles in the transformation of low-grade IPMN cysts to high-grade cysts en route to PDAC. Using multiplex immunofluorescent images of IPMN cysts, we adopted algorithms from spatial statistics and functional data analysis to create metrics that summarize the spatial interactions in IPMNs. We showed that an ensemble of models learned using these spatial metrics can robustly predict, with high accuracy, (1) the dysplasia grade (low vs high grade) and (2) the risk of a low-grade cyst progressing to a high-grade cyst. We obtained high classification accuracies on both tasks, with areas under the curve of 0.81 (95% confidence interval: 0.71-0.9) for task 1 and 0.81 (95% confidence interval: 0.7-0.94) for task 2. To the best of our knowledge, this is the first application of an ensemble machine learning approach for discovering critical cellular spatial interactions in IPMNs using imaging data . We envision that our work can be used as a risk assessment tool for patients diagnosed with IPMNs and facilitate greater understanding and investigation of the cellular interactions that cause transition of IPMNs to PDAC., Competing Interests: Declaration of conflicting interests:The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2018
- Full Text
- View/download PDF
31. Overexpression of the Transmembrane Protein IQGAP3 Is Associated with Poor Survival of Patients with Gastric Cancer.
- Author
-
Oue N, Yamamoto Y, Oshima T, Asai R, Ishikawa A, Uraoka N, Sakamoto N, Sentani K, and Yasui W
- Subjects
- Aged, Cell Line, Tumor, Female, Follow-Up Studies, Gastric Mucosa metabolism, Humans, Immunohistochemistry, Male, Membrane Proteins metabolism, Middle Aged, Mucins metabolism, Neoplastic Stem Cells metabolism, Phenotype, Prognosis, RNA Interference, Retrospective Studies, Spheroids, Cellular metabolism, Stomach Neoplasms diagnosis, Up-Regulation, GTPase-Activating Proteins metabolism, Gene Expression Regulation, Neoplastic, Stomach Neoplasms metabolism
- Abstract
Objective: Spheroid colony formation is a useful method of cancer stem cell (CSC) characterization. We previously showed that the IQ motif containing the GTPase-activating protein 3 gene (IQGAP3) is upregulated in spheroid body-forming gastric cancer (GC) cells compared with parental cells. We investigated IQGAP3 expression in GC., Methods: IQGAP3 protein expression was analyzed by immunohistochemistry in 165 GC cases. RNA interference was used to inhibit IQGAP3 expression in GC cell lines., Results: In non neoplastic gastric mucosa, weak staining of IQGAP3 was observed in the foveolar epithelium, while GC tissue showed stronger, more extensive staining. Of the 165 GC cases, 34 (21%) were positive for IQGAP3 expression. GC cases positive for IQGAP3 were found more frequently in stage II/III/IV cases than in stage I cases. Univariate and multivariate analyses demonstrated that IQGAP3 expression is an independent prognostic classifier of GC patients. Both the number and size of the spheres formed by MKN-74 cells were significantly reduced by knockdown of IQGAP3. The phosphorylation of Akt and Erk1/2 was inhibited by knockdown of IQGAP3., Conclusion: These results suggest that IQGAP3 plays an important role in gastric CSCs. The location of IQGAP3 on the cell membrane makes it a potential therapeutic target for GC., (© 2017 S. Karger AG, Basel.)
- Published
- 2018
- Full Text
- View/download PDF
32. TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma.
- Author
-
Pham QT, Oue N, Sekino Y, Yamamoto Y, Shigematsu Y, Sakamoto N, Sentani K, Uraoka N, and Yasui W
- Subjects
- Aged, Biomarkers, Tumor genetics, Carcinoma, Squamous Cell mortality, Carcinoma, Squamous Cell pathology, Carcinoma, Squamous Cell therapy, Cell Line, Tumor, Cell Proliferation, Chemotherapy, Adjuvant, Disease Progression, Esophageal Neoplasms mortality, Esophageal Neoplasms pathology, Esophageal Neoplasms therapy, Esophageal Squamous Cell Carcinoma, Esophagectomy, Female, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Humans, Hyaluronan Receptors metabolism, Immunohistochemistry, Kaplan-Meier Estimate, Male, Middle Aged, Neoplasm Staging, Neoplastic Stem Cells pathology, Retrospective Studies, Time Factors, Treatment Outcome, Tryptophan Oxygenase genetics, Up-Regulation, Biomarkers, Tumor metabolism, Carcinoma, Squamous Cell enzymology, Esophageal Neoplasms enzymology, Neoplastic Stem Cells enzymology, Tryptophan Oxygenase metabolism
- Abstract
Objective: Esophageal cancer is one of the deadliest cancers in the world, and the main subtype is esophageal squamous cell carcinoma (ESCC), which comprises 90% of cases. Expression of tryptophan 2,3-dioxygenase (TDO2), an enzyme involved in tryptophan catabolism, has been linked with tumor survival and poor prognosis of brain and breast cancer. However, no studies have investigated the potential role of TDO2 in esophageal cancer. Here we explored the expression and biological significance of TDO2 in ESCC., Methods: TDO2 protein expression was evaluated in 90 ESCC tissue samples by immunohistochemistry. TDO2 function in ESCC cell lines and spheroid colony formation were evaluated by RNA interference (RNAi)., Results: TDO2 overexpression was associated with tumor stage, recurrence status, and the CD44 cancer stem cell marker in ESCC. TDO2 overexpression was correlated with poor outcome of ESCC patients. Inhibition of TDO2 expression by RNAi in TE-10 and TE-11 cell lines reduced both the number and the size of spheroid colonies as well as cell proliferation. Knockdown of TDO2 expression also induced inactivation of the epidermal growth factor receptor signaling pathway., Conclusion: Our results imply that TDO2 could play an important role in the progression of ESCC. Furthermore, TDO2 may be a potential therapeutic target in ESCC., (© 2018 S. Karger AG, Basel.)
- Published
- 2018
- Full Text
- View/download PDF
33. 4-1BB Agonist Focuses CD8 + Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer.
- Author
-
Sakellariou-Thompson D, Forget MA, Creasy C, Bernard V, Zhao L, Kim YU, Hurd MW, Uraoka N, Parra ER, Kang Y, Bristow CA, Rodriguez-Canales J, Fleming JB, Varadhachary G, Javle M, Overman MJ, Alvarez HA, Heffernan TP, Zhang J, Hwu P, Maitra A, Haymaker C, and Bernatchez C
- Subjects
- Antibodies, Monoclonal immunology, Antibodies, Monoclonal pharmacology, CD8-Positive T-Lymphocytes drug effects, CD8-Positive T-Lymphocytes immunology, Cell Line, Tumor, Cell Proliferation drug effects, Humans, Linear Models, Lymphocytes, Tumor-Infiltrating immunology, Pancreatic Neoplasms immunology, Pancreatic Neoplasms pathology, Tumor Necrosis Factor Receptor Superfamily, Member 9 agonists, Immunotherapy, Adoptive methods, Lymphocytes, Tumor-Infiltrating transplantation, Pancreatic Neoplasms therapy, Tumor Necrosis Factor Receptor Superfamily, Member 9 immunology
- Abstract
Purpose: Survival for pancreatic ductal adenocarcinoma (PDAC) patients is extremely poor and improved therapies are urgently needed. Tumor-infiltrating lymphocyte (TIL) adoptive cell therapy (ACT) has shown great promise in other tumor types, such as metastatic melanoma where overall response rates of 50% have been seen. Given this success and the evidence showing that T-cell presence positively correlates with overall survival in PDAC, we sought to enrich for CD8
+ TILs capable of autologous tumor recognition. In addition, we explored the phenotype and T-cell receptor repertoire of the CD8+ TILs in the tumor microenvironment. Experimental Design: We used an agonistic 4-1BB mAb during the initial tumor fragment culture to provide 4-1BB costimulation and assessed changes in TIL growth, phenotype, repertoire, and antitumor function. Results: Increased CD8+ TIL growth from PDAC tumors was achieved with the aid of an agonistic 4-1BB mAb. Expanded TILs were characterized by an activated but not terminally differentiated phenotype. Moreover, 4-1BB stimulation expanded a more clonal and distinct CD8+ TIL repertoire than IL2 alone. TILs from both culture conditions displayed MHC class I-restricted recognition of autologous tumor targets. Conclusions: Costimulation with an anti-4-1BB mAb increases the feasibility of TIL therapy by producing greater numbers of these tumor-reactive T cells. These results suggest that TIL ACT for PDAC is a potential treatment avenue worth further investigation for a patient population in dire need of improved therapy. Clin Cancer Res; 23(23); 7263-75. ©2017 AACR ., (©2017 American Association for Cancer Research.)- Published
- 2017
- Full Text
- View/download PDF
34. Overexpression of KIFC1 and its association with spheroid formation in esophageal squamous cell carcinoma.
- Author
-
Imai T, Oue N, Yamamoto Y, Asai R, Uraoka N, Sentani K, Yoshida K, and Yasui W
- Subjects
- Aged, Aged, 80 and over, Carcinoma, Squamous Cell metabolism, Cell Line, Tumor, Down-Regulation, Esophageal Neoplasms metabolism, Esophageal Squamous Cell Carcinoma, Female, Humans, Immunohistochemistry methods, Kinesins genetics, Male, Middle Aged, Stomach Neoplasms pathology, Carcinoma, Squamous Cell genetics, Esophageal Neoplasms genetics, Gene Expression Regulation, Neoplastic, Kinesins metabolism, Neoplastic Stem Cells pathology, Stomach Neoplasms genetics
- Abstract
Esophageal squamous cell carcinoma (ESCC) is one of the most common human cancers. We previously reported that KIFC1 is involved in gastric cancer pathogenesis and that KIFC1 plays an important role in gastric cancer spheroid colony formation. However, the significance of KIFC1 in ESCC has not been examined. In the present study, we analyzed the expression and distribution of KIFC1 in 132 ESCC cases by immunohistochemistry. In contrast to weak or no staining of KIFC1 in non-neoplastic mucosa, ESCC tissue showed stronger, more extensive KIFC1 staining. In total, 95 (72%) of 132 ESCC cases were positive for KIFC1. Immunostaining of ALDH1 was also performed, and KIFC1-positive ESCC cases were significantly frequently found in ALDH1-positive ESCC cases compared with ALDH1-negative ESCC cases. Spheroid colony formation is an effective method to characterize CSCs, thus we analyzed sphere number and size at 15days in ESCC cells downregulated for KIFC1 by siRNA transfection. Both the number and size of sphere from TE-1 cells were significantly reduced in KIFC1 siRNA-transfected TE-1 cells than in negative control siRNA-transfected cells. These results suggest that KIFC1 plays an important role in ESCC pathogenesis., (Copyright © 2017 Elsevier GmbH. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
35. Validation of multiplex immunofluorescence panels using multispectral microscopy for immune-profiling of formalin-fixed and paraffin-embedded human tumor tissues.
- Author
-
Parra ER, Uraoka N, Jiang M, Cook P, Gibbons D, Forget MA, Bernatchez C, Haymaker C, Wistuba II, and Rodriguez-Canales J
- Subjects
- Biomarkers, Humans, Image Processing, Computer-Assisted, Neoplasms metabolism, Paraffin Embedding, Reproducibility of Results, Fluorescent Antibody Technique, Immunohistochemistry methods, Microscopy methods, Neoplasms pathology
- Abstract
Immune-profiling is becoming an important tool to identify predictive markers for the response to immunotherapy. Our goal was to validate multiplex immunofluorescence (mIF) panels to apply to formalin-fixed and paraffin-embedded tissues using a set of immune marker antibodies, with the Opal™ 7 color Kit (PerkinElmer) in the same tissue section. We validated and we described two panels aiming to characterize the expression of PD-L1, PD-1, and subsets of tumor associated immune cells. Panel 1 included pancytokeratin (AE1/AE3), PD-L1, CD4, CD8, CD3, CD68, and DAPI, and Panel 2 included pancytokeratin, PD-1, CD45RO, granzyme B, CD57, FOXP3, and DAPI. After all primary antibodies were tested in positive and negative controls by immunohistochemistry and uniplex IF, panels were developed and simultaneous marker expressions were quantified using the Vectra 3.0™ multispectral microscopy and image analysis InForm™ 2.2.1 software (PerkinElmer).These two mIF panels demonstrated specific co-localization in different cells that can identify the expression of PD-L1 in malignant cells and macrophages, and different T-cell subpopulations. This mIF methodology can be an invaluable tool for tumor tissue immune-profiling to allow multiple targets in the same tissue section and we provide that is accurate and reproducible method when is performed carefully under pathologist supervision.
- Published
- 2017
- Full Text
- View/download PDF
36. The Expression of BTS-2 Enhances Cell Growth and Invasiveness in Renal Cell Carcinoma.
- Author
-
Pham QT, Oue N, Yamamoto Y, Shigematsu Y, Sekino Y, Sakamoto N, Sentani K, Uraoka N, Tiwari M, and Yasui W
- Subjects
- Aged, Antigens, CD genetics, Carcinoma, Renal Cell genetics, Cell Line, Tumor, Cell Membrane metabolism, Cell Movement, Cell Proliferation, Female, GPI-Linked Proteins genetics, GPI-Linked Proteins metabolism, Gene Expression Regulation, Neoplastic, Humans, Kidney Neoplasms genetics, Male, RNA Interference, RNA, Messenger metabolism, RNA, Small Interfering genetics, Antigens, CD metabolism, Carcinoma, Renal Cell metabolism, Carcinoma, Renal Cell pathology, Kidney Neoplasms metabolism, Kidney Neoplasms pathology
- Abstract
Background: Renal cell carcinoma (RCC) is one of the most common types of cancer in developed countries. Bone marrow stromal cell antigen 2 (BST2) gene, which encodes BST2 transmembrane glycoprotein, is overexpressed in several cancer types. In the present study, we analyzed the expression and function of BST2 in RCC., Materials and Methods: BST2 expression was analyzed by immunohistochemistry in 123 RCC cases. RNA interference was used to inhibit BST2 expression in a RCC cell line., Results: Immunohistochemical analysis showed that 32% of the 123 RCC cases were positive for BST2. BST2 expression was positively associated with tumour stage. Furthermore, BST2 expression was an independent predictor of survival in patients with RCC. BST2 siRNA-transfected Caki-1 cells displayed significantly reduced cell growth and invasive activity relative to negative control siRNA-transfected cells., Conclusion: These results suggest that BST2 plays an important role in the progression of RCC. Because BST2 is expressed on the cell membrane, BST2 is a good therapeutic target for RCC., (Copyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
37. KIF11 Is Required for Spheroid Formation by Oesophageal and Colorectal Cancer Cells.
- Author
-
Imai T, Oue N, Sentani K, Sakamoto N, Uraoka N, Egi H, Hinoi T, Ohdan H, Yoshida K, and Yasui W
- Subjects
- Aged, Carcinoma, Squamous Cell genetics, Carcinoma, Squamous Cell mortality, Carcinoma, Squamous Cell pathology, Cell Line, Tumor, Colorectal Neoplasms genetics, Colorectal Neoplasms mortality, Colorectal Neoplasms pathology, Esophageal Neoplasms genetics, Esophageal Neoplasms mortality, Esophageal Neoplasms pathology, Esophageal Squamous Cell Carcinoma, Female, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Humans, Immunohistochemistry, Kaplan-Meier Estimate, Kinesins genetics, Male, Middle Aged, Neoplastic Stem Cells pathology, Prognosis, RNA Interference, Retrospective Studies, Signal Transduction, Spheroids, Cellular, Transfection, Carcinoma, Squamous Cell enzymology, Colorectal Neoplasms enzymology, Esophageal Neoplasms enzymology, Kinesins metabolism, Neoplastic Stem Cells enzymology
- Abstract
Background: Oesophageal squamous cell carcinoma (ESCC) and colorectal cancer (CRC) are common types of human cancer. Spheroid colony formation is used to characterize cancer stem cell (CSCs). In the present study, we analyzed the significance of kinesin family 11 (KIF11 in human ESCC and CRC., Materials and Methods: Expression of KIF11 in 105 ESCC and 100 CRC cases was determined using immunohistochemistry. RNA interference was used to inhibit KIF11 expression in ESCC and CRC cell lines., Results: In total, 61 out of 105 (58%) ESCC and 62 out of 100 (62%) CRC cases were positive for KIF11. Expression of KIF11 was not associated with any clinicopathological characteristics. Both the number and size of spheres produced by from TE-5 ESCC cells and DLD-1 CRC cells were significantly reduced upon KIF11 siRNA transfection compared to negative control siRNA transfection., Conclusion: These results indicate that KIF11 plays an important role in CSCs of ESCC and CRC., (Copyright© 2017 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
38. Autopsy of anaplastic carcinoma of the pancreas producing granulocyte colony-stimulating factor.
- Author
-
Hayashi H, Eguchi N, Sumimoto K, Matsumoto K, Azakami T, Sumida T, Tamura T, Sumii M, Uraoka N, and Shimamoto F
- Subjects
- Antineoplastic Combined Chemotherapy Protocols therapeutic use, Autopsy, Biopsy, Carcinoma drug therapy, Carcinoma pathology, Deoxycytidine administration & dosage, Deoxycytidine analogs & derivatives, Drug Combinations, Humans, Male, Middle Aged, Oxonic Acid administration & dosage, Pancreatic Neoplasms drug therapy, Pancreatic Neoplasms pathology, Tegafur administration & dosage, Tomography, X-Ray Computed, Gemcitabine, Carcinoma diagnostic imaging, Granulocyte Colony-Stimulating Factor biosynthesis, Pancreatic Neoplasms diagnostic imaging
- Abstract
A 50-year-old man presented to a nearby hospital with high fever and anorexia. An abdominal tumor was detected, and he was referred to our hospital. A pancreatic tumor was detected by computed tomography and abdominal ultrasonography. He had high fever, leukocytosis, and high serum granulocyte colony-stimulating factor (G-CSF). We performed a tumor biopsy and histological examination revealed anaplastic carcinoma of the pancreas. Based on the diagnosis, we initiated chemotherapy using gemcitabine plus S-1. However, the tumor rapidly progressed and he deteriorated and died 123 days after admission. As immunohistochemical study showed positive staining for G-CSF in the tumor cell, we diagnosed the tumor producing G-CSF during autopsy. Anaplastic carcinoma of the pancreas producing G-CSF is very rare, with 10 cases, including ours, reported in the literature.
- Published
- 2016
- Full Text
- View/download PDF
39. Regression of Cecal MALT Lymphoma after Antibiotic Treatment in a Patient with Helicobacter pylori Infection.
- Author
-
Yuge R, Kitadai Y, Tanaka S, Uraoka N, Sentani K, Yasui W, and Chayama K
- Subjects
- Anti-Bacterial Agents therapeutic use, Colonoscopy, Helicobacter Infections drug therapy, Helicobacter pylori, Humans, Lymphoma, B-Cell, Marginal Zone pathology, Male, Middle Aged, Helicobacter Infections complications, Lymphoma, B-Cell, Marginal Zone etiology
- Abstract
A 63-year-old man with abdominal discomfort was referred to our hospital. Colonoscopy revealed a hemispherical-shaped protruding cecal mass of approximately 10 mm in size with a normal mucosal surface. Biopsy specimens showed nodules consisting of the proliferation of atypical lymphoid cells. Mucosa-associated lymphoid tissue (MALT) lymphoma was diagnosed based on the histological and immunohistochemical findings. Since upper gastrointestinal endoscopy demonstrated Helicobacter pylori-associated atrophic gastritis, eradication therapy was administered. The cecal mass disappeared completely within three months after triple therapy. Therefore, H. pylori eradication therapy may be a useful treatment option for cecal MALT lymphoma.
- Published
- 2016
- Full Text
- View/download PDF
40. High-grade epithelial-myoepithelial carcinoma of the parotid gland with mucous cell differentiation.
- Author
-
Sentani K, Ogawa I, Uraoka N, Ikeda M, Hayashi N, Hattori T, Hattori Y, Oue N, Takata T, and Yasui W
- Subjects
- Aged, Biopsy, Fine-Needle, Cell Differentiation, Female, Goblet Cells pathology, Humans, Myoepithelioma surgery, Neoplasms, Glandular and Epithelial surgery, Parotid Gland pathology, Parotid Gland surgery, Parotid Neoplasms surgery, Myoepithelioma pathology, Neoplasms, Glandular and Epithelial pathology, Parotid Neoplasms pathology
- Abstract
Epithelial-myoepithelial carcinoma (EMC) is a rare salivary gland tumor with a low-grade malignancy, and EMC with high-grade histopathological features is exceedingly rare. Furthermore, EMC with intracellular mucin is also extremely rare. We report an uncommon case of a high-grade EMC of the parotid gland with mucous cell differentiation in a 66-year old Japanese woman who noticed a right palpable parotid mass increasing in size within a one-year period. The cytological specimen showed a focally biphasic structure and included isolated or discohesive piled-up clusters with hyaline globules surrounded by neoplastic cells with nuclear atypia. The gross examination revealed a relatively well-demarcated, multinodular gray-whitish and solid mass. Histologically, the tumor consisted of variably sized solid nests or trabeculae with central necrosis and increased mitotic activity, and invaded into adjacent skeletal muscles. Immunohistochemically, the biphasic ductal and myoepithelial differentiation of this tumor confirmed the diagnosis of high-grade EMC. Furthermore, numerous small nests with d-PAS and alcian blue-positive mucous cells predominated in about 5% of the whole tumor, and these mucous cells were encompassed by neoplastic myoepithelial cells. We should recognize this variant of EMC because we can't rule out the possibility of EMC even in the presence of mucous cells., (© 2015 Japanese Society of Pathology and Wiley Publishing Asia Pty Ltd.)
- Published
- 2015
- Full Text
- View/download PDF
41. The Potential Role of Inflammation Associated with Interaction between Osteopontin and CD44 in a Case of Pulmonary Tumor Thrombotic Microangiopathy Caused by Breast Cancer.
- Author
-
Higashi A, Dohi Y, Uraoka N, Sentani K, Uga S, Kinoshita H, Sada Y, Kitagawa T, Hidaka T, Kurisu S, Yamamoto H, Yasui W, and Kihara Y
- Subjects
- Aged, Autopsy, Breast Neoplasms pathology, Fatal Outcome, Female, Humans, Inflammation pathology, Lung pathology, Lung Neoplasms diagnosis, Neoplastic Cells, Circulating pathology, Thrombotic Microangiopathies diagnosis, Breast Neoplasms complications, Inflammation complications, Lung Neoplasms pathology, Neoplastic Cells, Circulating metabolism, Osteopontin blood, Thrombotic Microangiopathies pathology
- Abstract
Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare and fatal cancer-related complication. We herein present a case of PTTM that diagnosed antemortem by lung scintigraphy and pulmonary microvascular cytology. The patient was treated with steroid pulse therapy. Although her symptoms temporarily improved, she died of respiratory failure. An autopsy showed PTTM, and an immunohistochemical analysis revealed the expression of osteopontin and CD44 in macrophages that had migrated into the PTTM lesions. These findings suggest that inflammation associated with the interaction between osteopontin and CD44 may play an important role in PTTM.
- Published
- 2015
- Full Text
- View/download PDF
42. Overexpression of ZDHHC14 promotes migration and invasion of scirrhous type gastric cancer.
- Author
-
Oo HZ, Sentani K, Sakamoto N, Anami K, Naito Y, Uraoka N, Oshima T, Yanagihara K, Oue N, and Yasui W
- Subjects
- Adenocarcinoma, Scirrhous genetics, Aged, Cell Adhesion, Cell Line, Tumor, Cell Movement, Disease Progression, Female, Gene Expression Regulation, Neoplastic, Gene Knockdown Techniques, Humans, Male, Middle Aged, Neoplasm Invasiveness pathology, Stomach Neoplasms genetics, Up-Regulation, Acyltransferases genetics, Acyltransferases metabolism, Adenocarcinoma, Scirrhous pathology, Neoplasm Invasiveness genetics, Stomach Neoplasms pathology
- Abstract
Scirrhous type gastric cancer is highly aggressive and has a poorer prognosis than many other types of gastric carcinoma, due to its characteristic rapid cancer cell infiltration and proliferation, extensive stromal fibrosis, and frequent peritoneal dissemination. The aim of the present study was to identify novel prognostic markers or therapeutic targets for scirrhous type gastric cancer. We reviewed a list of genes with upregulated expression in scirrhous type gastric cancer and compared their expression with that in normal stomach from our previous Escherichia coli (E. coli) ampicillin secretion-trap (CAST) analysis. We focused on the ZDHHC14 gene, which encodes zinc finger, DHHC-type containing 14 protein. qRT-PCR analysis of ZDHHC14 in 41 gastric cancer cases revealed that compared to mRNA levels in normal non-neoplastic gastric mucosa, ZDHHC14 mRNA was overexpressed in 27% of gastric cancer tissue samples. The overexpression of ZDHHC14 was significantly associated with depth of tumor invasion, undifferentiated histology and scirrhous pattern. The invasiveness of ZDHHC14-knockdown HSC-44PE and 44As3 gastric cancer cells was decreased in comparison with that of the negative control siRNA-transfected cells, together with downregulation of MMP-17 mRNA. Integrins α5 and β1 were also downregulated in ZDHHC14-knockdown 44As3 cells. Forced expression of ZDHHC14 activated gastric cancer cell migration and invasion in vitro. These results indicate that ZDHHC14 is involved in tumor progression in patients with scirrhous type gastric cancer.
- Published
- 2014
- Full Text
- View/download PDF
43. Alpha-fetoprotein-producing clear cell carcinoma of the gallbladder with neuroendocrine differentiation.
- Author
-
Sentani K, Uraoka N, Oue N, and Yasui W
- Subjects
- Adenocarcinoma, Clear Cell pathology, Aged, Carcinoma, Neuroendocrine pathology, Cell Differentiation, Female, Gallbladder Neoplasms pathology, Humans, Immunohistochemistry, Adenocarcinoma, Clear Cell metabolism, Carcinoma, Neuroendocrine metabolism, Gallbladder Neoplasms metabolism, alpha-Fetoproteins metabolism
- Abstract
An uncommon case of alpha-fetoprotein (AFP) producing clear cell carcinoma of the gallbladder with neuroendocrine differentiation in a 78-year-old Japanese woman, who complained of epigastralgia, is reported. Macroscopically, the nodular infiltrative type of tumor, measuring approximately 4.5 × 3.5 cm in size, was located in the fundus of the gallbladder. Histologically, the tumor was composed of clear cell carcinoma with AFP production, non-clear cell adenocarcinoma with neuroendocrine differentiation, and poorly or undifferentiated carcinoma with extensive ulceration. Carcinoma in situ was found in the surrounding gallbladder epithelium. Her postoperative laboratory tests showed a decrease in AFP levels to normal. The clinical and pathologic significance of AFP production or neuroendocrine differentiation in the gallbladder carcinomas have thus far remained completely obscure. However, we should recognize the entity of this tumor because the accurate diagnosis of primary clear cell carcinoma of the gallbladder may have important therapeutic implications.
- Published
- 2014
- Full Text
- View/download PDF
44. MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis.
- Author
-
Sakamoto N, Naito Y, Oue N, Sentani K, Uraoka N, Oo HZ, Yanagihara K, Aoyagi K, Sasaki H, and Yasui W
- Subjects
- Cell Growth Processes physiology, Cell Line, Tumor, DNA Methylation, Down-Regulation, Female, Humans, Lymphatic Metastasis, Male, Matrix Metalloproteinase 7 metabolism, MicroRNAs metabolism, Middle Aged, Neoplasm Invasiveness, Prognosis, Stomach Neoplasms metabolism, Matrix Metalloproteinase 7 genetics, MicroRNAs genetics, Stomach Neoplasms genetics, Stomach Neoplasms pathology
- Abstract
Gastric cancer (GC) develops through deregulation of gene expression and accumulation of epigenetic abnormalities, leading to tumor cell acquisition of malignant features. MicroRNAs (miRNAs) play a critical role in cancer development where they can act as oncogenes or oncosuppressors. To identify miRNAs that are associated with some clinicopathologic features of GC and/or participate in tumor progression, miRNA expression in 20 GC tissues and five corresponding non-neoplastic gastric mucosa was examined by miRNA microarray. Oligonucleotide array analysis was carried out for miRNA target prediction. The functions of candidate miRNAs and their target genes were also analyzed by quantitative RT-PCR, Western blotting, reporter gene assay, and cell invasion assay. Comparison of miRNA expression profiles revealed that downregulation of miR-148a was identified in most of the GC tissues. Downregulation of miR-148a was significantly correlated with an advanced clinical stage, lymph node metastasis, and poor clinical outcome. Custom oligonucleotide array analysis revealed that MMP7 expression was markedly downregulated in miR-148a-overexpressing GC cells; MMP7 was found to be a direct and functional target of miR-148a, participating in cell invasion. These results suggest that miR-148a contributes to the maintenance of homeostasis in normal stomach tissue and plays an important role in GC invasion by regulating MMP7 expression., (© 2013 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd on behalf of Japanese Cancer Association.)
- Published
- 2014
- Full Text
- View/download PDF
45. Clinicopathological significance of MMP-7, laminin γ2 and EGFR expression at the invasive front of gastric carcinoma.
- Author
-
Sentani K, Matsuda M, Oue N, Uraoka N, Naito Y, Sakamoto N, and Yasui W
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Gene Expression Regulation, Neoplastic, Humans, Immunohistochemistry, Male, Middle Aged, Neoplasm Grading, Neoplasm Staging, Stomach Neoplasms genetics, Tissue Array Analysis, ErbB Receptors genetics, Laminin genetics, Matrix Metalloproteinase 7 genetics, Stomach Neoplasms pathology
- Abstract
Background: For several types of cancer, including gastric cancer (GC), tumor cells at the invasive front are considered to have a more aggressive behavior compared with those in the more central region. The aim of the present study was to analyze the expression of MMP-7, laminin γ2 and EGFR in a large number of GCs and to investigate how these expression patterns correlate with clinicopathologic parameters, infiltrative patterns, histology or mucin phenotype., Methods: We immunohistochemically examined the expression of MMP-7, laminin γ2 and EGFR using a tissue microarray analysis of 790 GCs, and evaluated their clinicopathological significance., Results: MMP-7, cytoplasmic laminin γ2, extracellular laminin γ2 and EGFR expression were observed in 25, 25, 8 and 21 % of the 790 GC cases, respectively. Expression of MMP-7, cytoplasmic laminin γ2 and EGFR was associated with advanced T grade, N grade and tumor stage. Extracellular laminin γ2 expression was not associated with any clinicopathologic parameters, infiltrative patterns, histology or mucin phenotype. Furthermore, we investigated the correlations of MMP-7, laminin γ2 and EGFR expression. MMP-7 expression was significantly more frequent in positive expression of cytoplasmic laminin γ2 than negative cases, and EGFR expression was significantly more frequent in positive expression of cytoplasmic laminin γ2 and MMP-7., Conclusions: Molecular expression of MMP-7, laminin γ2 or EGFR, and their combinations, may be associated with GC tumor aggressiveness. Assessment of expression of these molecules at the invasive front of primary tumors is clinically significant in predicting the malignant behavior of GC.
- Published
- 2014
- Full Text
- View/download PDF
46. NRD1, which encodes nardilysin protein, promotes esophageal cancer cell invasion through induction of MMP2 and MMP3 expression.
- Author
-
Uraoka N, Oue N, Sakamoto N, Sentani K, Oo HZ, Naito Y, Noguchi T, and Yasui W
- Subjects
- Aged, Biomarkers, Tumor genetics, Biomarkers, Tumor metabolism, Cell Line, Tumor, Enzyme Induction, Esophageal Neoplasms enzymology, Esophageal Neoplasms genetics, Female, Humans, Male, Matrix Metalloproteinase 2 genetics, Matrix Metalloproteinase 2 metabolism, Matrix Metalloproteinase 3 genetics, Matrix Metalloproteinase 3 metabolism, Metalloendopeptidases genetics, Neoplasm Invasiveness, Prognosis, Up-Regulation, Esophageal Neoplasms metabolism, Esophageal Neoplasms pathology, Matrix Metalloproteinase 2 biosynthesis, Matrix Metalloproteinase 3 biosynthesis, Metalloendopeptidases metabolism
- Abstract
Esophageal squamous cell carcinoma (ESCC) is one of the most common malignancies worldwide. In the present study, to identify novel prognostic markers or therapeutic targets for ESCC, we reviewed a list of genes with upregulated expression in ESCC compared with normal esophagus, as identified by our serial analysis of gene expression (SAGE) analysis. We focused on the NRD1 gene, which encodes the nardilysin protein. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) in 34 ESCC tissue samples revealed that mRNA expression of NRD1 was upregulated in 56% of ESCC tissue samples. Immunohistochemical analysis of nardilysin in 109 ESCC tissue samples demonstrated that 43 (39%) ESCC cases were positive for nardilysin. Nardilysin-positive ESCC cases were more advanced in terms of T classification (P = 0.0007), N classification (P = 0.0164), and tumor stage (P < 0.0001) than nardilysin-negative ESCC cases. Furthermore, nardilysin expression was significantly associated with poorer prognosis (P = 0.0258). Univariate and multivariate analyses revealed that nardilysin expression is an independent prognostic classifier of patients with ESCC. The invasiveness of NRD1-knockdown TE1 and TE5 esophageal cancer cell lines was less than that of the negative control siRNA-transfected cell lines. Expression of MMP2 and MMP3 mRNA was significantly lower in NRD1-knockdown TE5 cells than in negative control siRNA-transfected cells. These results suggest that nardilysin is involved in tumor progression, and is an independent prognostic classifier in patients with ESCC., (© 2013 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd on behalf of Japanese Cancer Association.)
- Published
- 2014
- Full Text
- View/download PDF
47. Liver-intestine cadherin induction by epidermal growth factor receptor is associated with intestinal differentiation of gastric cancer.
- Author
-
Sakamoto N, Oue N, Sentani K, Anami K, Uraoka N, Naito Y, Oo HZ, Hinoi T, Ohdan H, Yanagihara K, Aoyagi K, Sasaki H, and Yasui W
- Subjects
- Cadherins metabolism, Epidermal Growth Factor pharmacology, Gene Expression Profiling, Gene Expression Regulation, Neoplastic drug effects, HT29 Cells, Humans, Intestinal Mucosa metabolism, Intestines pathology, Ligands, Liver metabolism, Liver pathology, Neoplasm Staging, Stomach Neoplasms pathology, Transforming Growth Factor alpha pharmacology, Cadherins genetics, ErbB Receptors metabolism, Stomach Neoplasms genetics, Stomach Neoplasms metabolism
- Abstract
Gastric cancer (GC) is one of the most common malignancies worldwide. The epidermal growth factor receptor (EGFR) molecule is very important in GC progression. To examine the correlation between EGFR and GC-related genes, we analyzed gene expression profiles of HT-29 cells treated with EGFR ligands and identified six genes upregulated by epidermal growth factor (EGF) and transforming growth factor (TGF)-α treatment. Among these, we focused on cadherin 17 (CDH17) encoding liver-intestine cadherin (LI-cadherin). Expression of LI-cadherin was induced by both EGF and TGF-α, as detected by quantitative RT-PCR and Western blot analysis. A luciferase assay showed that LI-cadherin promoter activity was enhanced by EGF or TGF-α in both HT-29 cells and MKN-74 GC cells. Immunohistochemical analysis of 152 GC cases showed that out of 58 LI-cadherin-positive cases, 24 (41%) cases were also positive for EGFR, whereas out of 94 LI-cadherin-negative cases, only 9 (10%) cases were positive for EGFR (P < 0.0001). Double-immunofluorescence staining revealed that EGFR and LI-cadherin were coexpressed. Significant correlation was found between LI-cadherin expression and advanced T grade and N grade. Both EGFR and LI-cadherin expression were more frequently found in GC cases with an intestinal mucin phenotype than in cases with a gastric mucin phenotype. These results indicate that, in addition to the known intestinal transcription factor caudal type homeobox 2, EGFR activation induces LI-cadherin expression and participates in intestinal differentiation of GC., (© 2012 Japanese Cancer Association.)
- Published
- 2012
- Full Text
- View/download PDF
48. Infantile adenomyoma subclinically excreted into the patient's diaper.
- Author
-
Anami K, Sentani K, Sakamoto N, Uraoka N, Oue N, and Yasui W
- Subjects
- Abnormalities, Multiple, Adenomyoma metabolism, Biomarkers, Tumor metabolism, Defecation, Diapers, Infant, Female, Gastrointestinal Neoplasms metabolism, Humans, Incidental Findings, Infant, Rare Diseases, Adenomyoma diagnosis, Gastrointestinal Neoplasms diagnosis
- Abstract
Adenomyoma is a rare condition of the gastrointestinal tract, consisting of glandular structures lined by columnar or cuboidal epithelium and surrounded by smooth muscle bundles. The vast majority of adenomyomas of gastrointestinal tract have been reported to be located at the propyloric segment of the stomach and their localization in the bowel of infantile patients is considered rare. A review of the literature showed that 13 cases of infantile adenomyoma in the bowel have been reported. In the previous cases, intussusception was the most common complication of adenomyoma in the bowel and all cases underwent laparotomy. Here we describe an extremely rare case of infantile adenomyoma subclinically eliminated in the diaper. In addition, we performed immunohistochemical analysis to speculate on the origin of the adenomyoma., (© 2012 The Authors. Pathology International © 2012 Japanese Society of Pathology and Blackwell Publishing Asia Pty Ltd.)
- Published
- 2012
- Full Text
- View/download PDF
49. Primary mammary mucinous cystadenocarcinoma: cytological and histological findings.
- Author
-
Sentani K, Tashiro T, Uraoka N, Aosaki Y, Yano S, Takaeko F, and Yasui W
- Subjects
- Aged, Biopsy, Fine-Needle, Breast pathology, Breast Neoplasms chemistry, Breast Neoplasms diagnosis, Cystadenocarcinoma, Mucinous chemistry, Cystadenocarcinoma, Mucinous diagnosis, Cytoplasm pathology, Female, Humans, Immunohistochemistry methods, Mucins chemistry, Breast Neoplasms pathology, Cystadenocarcinoma, Mucinous pathology
- Abstract
Mucinous cystadenocarcinoma (MCA), commonly encountered in the ovary or pancreas, is rare in the breast and was only recently described as a distinct variant of invasive ductal carcinoma of the breast. Only 11 cases of primary mammary MCA have been reported. In this article, we report a case of primary mammary MCA with focus on cytological and histological findings. A 65-year-old female noticed right palpable breast mass. Sonography showed an irregularly shaped 2.8 × 2.4 cm lesion in the upper outer quadrant of the right breast. Fine-needle aspiration cytology was performed on the right breast nodule, and cytopathologic examination suggested an adenocarcinoma composed of tall columnar cells with mucin. A partial mastectomy of the right breast and the axillary lymph nodes dissection was performed. The gross examination revealed a well-demarcated and mucus-filled tumor. Histologically, it had complex papillae, some of which were supported by delicate fibrovascular stroma lined by simple to slightly stratified columnar neoplastic epithelial cells with intracellular mucin, coexisting with MCA in situ and ordinary intraductal carcinoma component (ICC). Immunohistochemically, ICC was HER2-negative and estrogen receptor/progesterone receptor-positive, while MCA was triple negative. MCA might be derived from a metaplasia of ordinary ICC, but its pathogenesis and biologic behavior remains unclear. Despite the invasive nature of mammary MCA, these carcinomas appear to be associated with a good prognosis. The patient has remained well and disease-free for 6 months after the operation., (Copyright © 2011 Wiley Periodicals, Inc.)
- Published
- 2012
- Full Text
- View/download PDF
50. Cytokeratin 7 is a predictive marker for survival in patients with esophageal squamous cell carcinoma.
- Author
-
Oue N, Noguchi T, Anami K, Kitano S, Sakamoto N, Sentani K, Uraoka N, Aoyagi K, Yoshida T, Sasaki H, and Yasui W
- Subjects
- Aged, Carcinoma, Squamous Cell metabolism, Carcinoma, Squamous Cell pathology, Esophageal Neoplasms metabolism, Esophageal Neoplasms pathology, Female, Follow-Up Studies, Humans, Immunoenzyme Techniques, Lymphatic Metastasis, Male, Neoplasm Staging, Prognosis, Retrospective Studies, Survival Rate, Biomarkers, Tumor metabolism, Carcinoma, Squamous Cell mortality, Esophageal Neoplasms mortality, Keratin-7 metabolism
- Abstract
Background: Patients diagnosed with stage II and III esophageal squamous cell carcinoma (ESCC) have variable prognosis. This group would benefit greatly from the discovery of prognostic markers that are capable of identifying individuals for whom adjuvant treatment would be advantageous. The aim of this study was to investigate the impact of immunohistochemically detected cytokeratin 7 (CK7) expression on disease-free survival, overall survival (OS), or therapeutic outcome in patients with ESCC., Methods: Immunohistochemical analysis of CK7 was performed on 225 surgically resected specimens of stage 0-III ESCC., Results: In total, 20 (9%) of 225 ESCC cases were positive for CK7. In stage 0-III ESCC patients, CK7 expression was statistically significantly associated with OS, independent of clinical covariates, including tumor, node, metastasis system stage. In stage II and III ESCC patients (n = 124), CK7 expression was significantly associated with poorer OS (P = 0.0377). Furthermore, in stage II and III ESCC patients who did not receive adjuvant chemotherapy (n = 73), CK7 expression was significantly associated with poorer OS (P = 0.0003). CK7 expression was not associated with therapeutic outcome in patients with stage II and III ESCC who received adjuvant chemotherapy. In patients with CK7-positive ESCC (n = 16), receipt of adjuvant chemotherapy tended to be beneficial for patients with stage II and III ESCC (P = 0.0654)., Conclusions: Immunohistochemical analysis of CK7 will help to identify high-risk patients.
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.